Both in Pharmaceuticals
CorMedix vs Phathom Pharmaceuticals
Over the past year CRMD returned −50.4% and PHAT returned −57.9%; their daily moves had a correlation of 0.26.
CRMD −50.4% PHAT −57.9%Growth of $1, one year, split-adjusted
| Metric | CRMD | PHAT |
|---|---|---|
| Price | $5.66 | $5.68 |
| Market cap | $441.2M | $461.7M |
| Today | +1.80% | −1.05% |
| 1 month | −22.3% | −16.2% |
| 6 months | −29.7% | −55.2% |
| Year to date | −51.3% | −65.8% |
| 1 year | −51.0% | −58.6% |
| Revenue growth (YoY) | +156.5% | +71.1% |
| Gross margin | 75.7% | 78.3% |
| Net margin | 25.5% | −16.4% |
| P/E (TTM) | 2.4× | — |
| Price / sales | 1.0× | 1.7× |
| Net cash | $256.7M | $17.6M |
| Dividend yield | — | — |
| Volatility (60d) | 77.3% | 72.0% |
| Short % of float | 20.8% | 17.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).